Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

During the Trading Day
19.54 +0.01 / +0.05%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
19.54 -0.0023 / -0.01%
 
Volume: 2.9K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues152.4M183.6M244.8M289.0M
 
 
 
 
 
Cost of Goods Sold130.0M146.5M116.2M193.1M
 
 
 
 
 
Depreciation And Amortization3.6M6.0M7.1M9.5M
 
 
 
 
 
 
Operating ExpensesGross Income18.8M31.1M121.5M86.4M
 
 
 
 
 
General Expenses37.9M47.2M56.0M70.0M
 
 
 
 
 
Research And Development12.8M17.1M19.8M26.8M
 
 
 
 
 
Total Operating Expenses171.5M199.7M179.2M272.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.1M-16.1M65.5M16.3M
 
 
 
 
 
Extraordinary Credit0.000.007.9M0.00
 
 
Extraordinary Charge-838.0K-1.1M-44.5M-1.3M
 
 
 
 
 
Pre-Tax Equity Earnings-2.5M1.3M2.4M4.0M
 
 
 
 
 
Interest Expense On Debt4.2M1.2M930.0K2.2M
 
 
 
 
 
Other Expenses0.000.000.00-678.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.4M-16.8M30.5M16.2M
 
 
 
 
 
Income Taxes0.000.00-895.0K-23.7M
 
 
 
Net Income-26.4M-16.8M29.6M39.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.1M28.0M29.2M31.9M
 
 
 
 
 
Shares To Calculate EPS Diluted20.1M28.0M29.9M32.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.31-$0.60$0.99$1.22
 
 
 
 
 
EPS Diluted-$1.31-$0.60$0.99$1.22